← SynDRA
BENFOTIAMINE
SynDRA canonical compound SYN0039861 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | AGER |
|---|
| Mechanism of action | antioxidant |
|---|
| Indication | lumbago |
|---|
| Disease area | rheumatology |
|---|
All known targets
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PDE4D
- ADORA1
- NR1I2
- HRH2
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- LMNA
- MAOA
- MC3R
- MLNR
- NPY1R
- NR3C1
- ADORA2A
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PGR
- PTGS2
- SAMHD1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- TBXA2R
- HRH1
- HDAC6
- GHSR
- CCKBR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adjuvants, Immunologic
- Chelating Agents
- antioxidant
ATC classes
- A11D · VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12
Cross-references
Synonyms
- benfothiamine
- benzoylthiamine monophosphate
- betivina
- bietamine
- Benfotiamina
- Benfothiamine
- Benphothiamine
- Benzoylthiamine monophosphate
- Benzoylthiamine o-monophosphate
- Benzoylthiaminmonophosphat
- Biotamin
- S-benzoylthiamine monophosphate
- S-benzoylthiamine o-monophosphate
- 8088 C.B
- 8088 C.B.
- 8088-CB
- 8088CB
- NSC-758241
- (3Z)-4-{N-[(4-amino-2-methylpyrimidin-5-yl)methyl]carbonylamino}-3-(phenylcarb onylthio)pent-3-enyl dihydrogen phosphate
- (Z)-S-(2-(N-((4-amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl) benzothioate
- {[(3Z)-4-{N-[(4-amino-2-methylpyrimidin-5-yl)methyl]formamido}-3-[(Z)-benzoylsulfanyl]pent-3-en-1-yl]oxy}phosphonic acid
- 22457-89-2 (free acid)
- AC-8280
- AKOS015920320
- Benfotamine
- Benfotiamine (JAN/INN)
- Benfotiaminum
- Betivina
- Biotamin (TN)
- BPBio1_000757
- BSPBio_000687
- CAS-22457-89-2
- CCG-220654
- CHEBI:41039
- CHEMBL4303665
- D01255
- DB11748
- DTXCID1025433
Look up BENFOTIAMINE in the interactive SynDRA portal →